Dashboard
Manage Tickers

AQSTAquestive Therapeutics, Inc.

Nasdaq aquestive.com


$ 3.42 $ 0.14 (4.26 %)    

Friday, 09-Aug-2024 15:59:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 450.22 $ 2.34 (0.52 %)
DIA $ 395.16 $ 0.63 (0.16 %)
SPY $ 532.81 $ 2.34 (0.44 %)
TLT $ 96.28 $ 0.94 (0.99 %)
GLD $ 224.54 $ 0.55 (0.25 %)
$ 3.43
$ 3.42 x 400
-- x --
-- - --
$ 1.25 - $ 6.23
1,946,685
na
311.83M
$ 1.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-05-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 03-08-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 03-09-2021 12-31-2020 10-K
16 11-04-2020 09-30-2020 10-Q
17 08-04-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 03-11-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-14-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 09-04-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aquestive-therapeutics-sees-fy24-revenue-57m-60m-vs-49792m-est
Aquestive Therapeutics Sees FY24 Revenue $...
08/06/2024 21:59:55

aquestive-therapeutics-q2-2024-gaap-eps-003-beats-011-estimate-sales-20099m-beat-12380m-estimate
Aquestive Therapeutics Q2 2024 GAAP EPS $(...
08/06/2024 21:30:35

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate o...

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
07/26/2024 11:06:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

aquestive-therapeutics-releases-topline-pk-data-from-self-administration-study-of-anaphylm-meets-primary-endpoints-with-comparable-pk-whether-administered-by-subjects-or-hcps-final-oas-challenge-study-enrolling-pre-nda-meeting-anticipated-by-end-of-q3-2024
Aquestive Therapeutics Releases Topline PK...
07/25/2024 12:05:16

Meets primary study endpoints with pharmacokinetics (PK) comparable whether Anaphylm is administered by subjects or by healthca...

jmp-securities-reiterates-market-outperform-on-aquestive-therapeutics-maintains-9-price-target
JMP Securities Reiterates Market Outperfor...
06/26/2024 16:03:57

JMP Securities analyst Jason Butler reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Market Outperform and maintains $...

oral-allergy-medication-for-emergencies---aquestive-therapeutics-investigational-therapy-works-even-with-exposure-to-liquids-of-different-temperatures-data-shows
Oral Allergy Medication For Emergencies - ...
06/25/2024 17:00:29

Aquestive Therapeutics released topline pharmacokinetic data for Anaphylm (epinephrine) Sublingual Film for severe allergic rea...

aquestive-therapeutics-reports-topline-data-from-temperature--ph-study-of-anaphylm-sublingual-film
Aquestive Therapeutics Reports Topline Dat...
06/25/2024 12:05:36

Anaphylm pharmacokinetic results unaffected by oral cavity exposure to liquids of different temperatures and pHRemains on track...

aquestive-therapeutics-to-join-russell-3000-and-russell-2000-indexes-effective-june-28-2024
Aquestive Therapeutics To Join Russell 300...
06/18/2024 12:15:27

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
06/05/2024 11:17:02

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

aquestive-therapeutics-appoints-cassie-jung-as-coo
Aquestive Therapeutics Appoints Cassie Jun...
06/03/2024 12:28:17

aquestive-therapeutics-announces-two-encore-poster-presentations-highlighting-positive-pk-and-pd-data-from-clinical-studies-for-anaphylm-epinephrine-sublingual-film-at-the-eastern-allergy-conference-from-may-30-to-june-2
Aquestive Therapeutics Announces Two Encor...
05/28/2024 12:31:38

leerink-partners-initiates-coverage-on-aquestive-therapeutics-with-outperform-rating-announces-price-target-of-8
Leerink Partners Initiates Coverage On Aqu...
05/10/2024 19:00:19

Leerink Partners analyst Roanna Ruiz initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Outperform rating and...

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
05/09/2024 11:21:50

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

aquestive-therapeutics-continues-to-expect-fy24-total-revenue-of-48m-51m-est-50214m
Aquestive Therapeutics Continues To Expect...
05/07/2024 22:02:25

Cash and cash equivalents were $95.2 million as of March 31, 2024. Extended cash runway into 2026 with completion of $77.5 mill...

aquestive-therapeutics-q1-2024-gaap-eps-017-misses-007-estimate-sales-12053m-miss-12262m-estimate
Aquestive Therapeutics Q1 2024 GAAP EPS $(...
05/07/2024 21:48:56

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate...

hc-wainwright--co-reiterates-buy-on-aquestive-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Aque...
04/30/2024 10:31:46

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

aquestive-therapeutics-receives-fda-approval-and-market-access-for-libervant-buccal-film-in-pediatric-patients-ages-2-to-5
Aquestive Therapeutics Receives FDA Approv...
04/29/2024 11:04:54

ally-financial-reports-upbeat-earnings-joins-badger-meter-genuine-parts-and-other-big-stocks-moving-higher-on-thursday
Ally Financial Reports Upbeat Earnings, Jo...
04/18/2024 17:58:44

aquestive-therapeutics-to-present-crossover-study-data-for-libervant-buccal-film-at-76th-annual-meeting-of-american-academy-of-neurology
Aquestive Therapeutics To Present Crossove...
04/12/2024 20:02:53

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION